These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 831874
1. Rabbit factor VIII: identification of size heterogeneity. Rick ME, Wampler DE, Hoyer LW. Blood; 1977 Feb; 49(2):209-17. PubMed ID: 831874 [Abstract] [Full Text] [Related]
2. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment. Cooper HA, Reisner FF, Hall M, Wagner RH. J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490 [Abstract] [Full Text] [Related]
3. Characterization of a form of bovine factor VIII which does not aggregate human platelets. Kirby EP. Thromb Haemost; 1981 Aug 28; 46(2):479-84. PubMed ID: 6795738 [Abstract] [Full Text] [Related]
4. Molecular structural studies of human factor VIII. McKee PA, Andersen JC, Switzer ME. Ann N Y Acad Sci; 1975 Jan 20; 240():8-33. PubMed ID: 122889 [Abstract] [Full Text] [Related]
5. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation. Hoyer LW, Trabold NC. J Lab Clin Med; 1981 Jan 20; 97(1):50-64. PubMed ID: 6778941 [Abstract] [Full Text] [Related]
6. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. Switzer ME, McKee PA. J Clin Invest; 1976 Apr 20; 57(4):925-37. PubMed ID: 1084890 [Abstract] [Full Text] [Related]
8. Dissociation of factor VIII in the presence of proteolytic inhibitors. Sussman II, Weiss HJ. Thromb Haemost; 1978 Oct 31; 40(2):316-25. PubMed ID: 310586 [Abstract] [Full Text] [Related]
10. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin. Switzer ME, McKee PA. J Clin Invest; 1977 Oct 31; 60(4):819-28. PubMed ID: 408379 [Abstract] [Full Text] [Related]
12. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin. Lazarchick J, Ashby MA, Lazarchick JJ, Sens DA. Ann Clin Lab Sci; 1986 Oct 31; 16(6):497-501. PubMed ID: 3099625 [Abstract] [Full Text] [Related]
13. The properties of immune complexes formed by human antibodies to factor VIII. Lazarchick J, Hoyer LW. J Clin Invest; 1977 Nov 31; 60(5):1070-9. PubMed ID: 908750 [Abstract] [Full Text] [Related]
14. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. Weinstein MJ, Chute LE. J Clin Invest; 1984 Feb 31; 73(2):307-16. PubMed ID: 6421875 [Abstract] [Full Text] [Related]
15. Binding of low-molecular-weight canine factor VIII coagulant from von Willebrand plasma to canine factor VIII-related antigen. Benson RE, Johnson GS, Dodds WJ. Br J Haematol; 1981 Dec 31; 49(4):541-50. PubMed ID: 6797460 [Abstract] [Full Text] [Related]
16. Immunologic studies of native and modified human factor VIII/von Willebrand factor. Switzer ME, McKee PA. Blood; 1979 Aug 31; 54(2):310-21. PubMed ID: 88237 [Abstract] [Full Text] [Related]
17. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids. Muntean W, Rothwangl HJ. Eur J Clin Invest; 1984 Dec 31; 14(6):462-8. PubMed ID: 6441724 [Abstract] [Full Text] [Related]
18. Thrombin activation of factor VIII. II. A comparison of purified factor VIII and the low molecular weight factor VIII procoagulant. Rick ME, Hoyer LW. Br J Haematol; 1978 Jan 31; 38(1):107-19. PubMed ID: 638056 [Abstract] [Full Text] [Related]
19. Thrombin activation of factor VIII: the effect of inhibitors. Rick ME, Hoyer LW. Br J Haematol; 1977 Aug 31; 36(4):585-97. PubMed ID: 889721 [Abstract] [Full Text] [Related]
20. Studies on human factor VIII and its antibodies using radiolabelling and affinity chromatography. Kavanagh ML, Wood CN, Davidson JF. Thromb Haemost; 1981 Jun 30; 45(3):267-71. PubMed ID: 6792739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]